[Clinical picture and diagnosis of neurotrophic keratopathy].

Klinik und Diagnose der neurotrophen Keratopathie.
Corneal epithelial defect Corneal nerves Corneal sensation Corneal ulcer Staged treatment

Journal

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 12 12 2018
medline: 26 7 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Neurotrophic keratopathy is characterized by corneal surface alterations, persistent corneal epithelial defects and/or corneal ulcerations associated with corneal sensory abnormalities. Due to the variable clinical picture neurotrophic keratopathy is often overlooked or diagnosed too late in the course of the disease. Discussion of the clinical picture of neurotrophic keratopathy and recommendations for correct diagnosis. Analysis of the existing literature and discussion of basic recent publications. Neurotrophic keratopathy is defined as a disease related to alterations in corneal nerves leading to impairment in sensory and trophic function with consequent breakdown of the corneal epithelium affecting health and integrity of the tear film, epithelium and stroma. It can occur with infections, autoimmune diseases, after trauma or ocular surgery, with intracranial neoplasia, in systemic diseases and genetic syndromes. It is classified into three stages: mild (epithelial changes without epithelial defects), moderate (epithelial defects) and severe (stromal involvement). The clinical hallmark is reduced or absent corneal sensation. Therefore, corneal sensitivity testing is essential in the diagnosis of neurotrophic keratopathy along with the patient history, clinical examination and diagnostic tests, such as vital stains and, if possible, in vivo confocal microscopy. The correct diagnosis and classification of neurotrophic keratopathy enable a stage-adapted step-ladder therapeutic approach with subsequent reduction of progression and complications of the disease.

Sections du résumé

BACKGROUND BACKGROUND
Neurotrophic keratopathy is characterized by corneal surface alterations, persistent corneal epithelial defects and/or corneal ulcerations associated with corneal sensory abnormalities. Due to the variable clinical picture neurotrophic keratopathy is often overlooked or diagnosed too late in the course of the disease.
OBJECTIVE OBJECTIVE
Discussion of the clinical picture of neurotrophic keratopathy and recommendations for correct diagnosis.
MATERIAL AND METHODS METHODS
Analysis of the existing literature and discussion of basic recent publications.
RESULTS RESULTS
Neurotrophic keratopathy is defined as a disease related to alterations in corneal nerves leading to impairment in sensory and trophic function with consequent breakdown of the corneal epithelium affecting health and integrity of the tear film, epithelium and stroma. It can occur with infections, autoimmune diseases, after trauma or ocular surgery, with intracranial neoplasia, in systemic diseases and genetic syndromes. It is classified into three stages: mild (epithelial changes without epithelial defects), moderate (epithelial defects) and severe (stromal involvement). The clinical hallmark is reduced or absent corneal sensation. Therefore, corneal sensitivity testing is essential in the diagnosis of neurotrophic keratopathy along with the patient history, clinical examination and diagnostic tests, such as vital stains and, if possible, in vivo confocal microscopy.
CONCLUSION CONCLUSIONS
The correct diagnosis and classification of neurotrophic keratopathy enable a stage-adapted step-ladder therapeutic approach with subsequent reduction of progression and complications of the disease.

Identifiants

pubmed: 30535856
doi: 10.1007/s00347-018-0822-x
pii: 10.1007/s00347-018-0822-x
doi:

Types de publication

Journal Article Review

Langues

ger

Pagination

120-126

Références

Eye (Lond). 2003 Nov;17(8):989-95
pubmed: 14631406
Ophthalmologe. 2005 Jan;102(1):7-14
pubmed: 15538584
Eye (Lond). 2006 Jul;20(7):837-9
pubmed: 16215544
Klin Monbl Augenheilkd. 2005 Nov;222(11):901-4
pubmed: 16308823
Cornea. 2008 Sep;27 Suppl 1:S70-6
pubmed: 18813078
Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1307-12
pubmed: 20490534
Ophthalmologe. 2010 Oct;107(10):911-7
pubmed: 20803019
Korean J Ophthalmol. 2011 Jun;25(3):210-3
pubmed: 21655049
Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3154-60
pubmed: 22511623
Ophthalmology. 1990 Mar;97(3):308-12
pubmed: 2336268
JAMA Ophthalmol. 2013 Dec;131(12):1547-53
pubmed: 24158681
Surv Ophthalmol. 2014 May-Jun;59(3):263-85
pubmed: 24461367
Clin Ophthalmol. 2014 Mar 19;8:571-9
pubmed: 24672223
Ophthalmology. 2014 Nov;121(11):2153-8
pubmed: 24935283
Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):765-72
pubmed: 25644620
Eur J Ophthalmol. 2015 May 25;25(4):e35-7
pubmed: 25655592
Acta Ophthalmol. 2016 Feb;94(1):e6-10
pubmed: 25847294
Br J Ophthalmol. 2016 Mar;100(3):315-22
pubmed: 26163540
Biomed Res Int. 2015;2015:805876
pubmed: 26451380
J Fr Ophtalmol. 2016 Feb;39(2):195-201
pubmed: 26679387
Ocul Surf. 2017 Jan;15(1):15-47
pubmed: 27771327
Ocul Surf. 2017 Jul;15(3):404-437
pubmed: 28736339
Ocul Surf. 2018 Apr;16(2):218-225
pubmed: 29305292
Prog Retin Eye Res. 2018 Sep;66:107-131
pubmed: 29698813
Arch Ophthalmol. 1977 Dec;95(12):2193-6
pubmed: 588113
Br J Ophthalmol. 1993 Oct;77(10):679-80
pubmed: 8218042
Cornea. 1996 Mar;15(2):135-8
pubmed: 8925660
Am J Ophthalmol. 1998 Nov;126(5):725-7
pubmed: 9822241

Auteurs

E M Messmer (EM)

Augenklinik, Ludwig-Maximilians-Universität München, Mathildenstr. 8, 80336, München, Deutschland. emessmer@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH